1,027 results match your criteria: "Service Hospitalo-Universitaire[Affiliation]"
Eur J Psychotraumatol
August 2024
Department of Child and Adolescent Psychiatry, Saint Eloi University Hospital, Montpellier, France.
Strong familial bonds are crucial to building resilience among youth exposed to traumatic events in socially adverse environments. Exploring parental experiences in the aftermath of adolescents' traumatic exposure in these settings would help tailor early interventions. We qualitatively explored experiences and perceived needs among parents of teenagers aged 11-16 years who were exposed in the last three months to a potentially traumatic event in Beirut, Lebanon.
View Article and Find Full Text PDFNat Commun
July 2024
Institut Pasteur, Experimental Neuropathology Unit, Global Health Department, Paris, France.
Serotonin reuptake inhibitor antidepressants such as fluoxetine are widely used to treat mood disorders. The mechanisms of action include an increase in extracellular level of serotonin, neurogenesis, and growth of vessels in the brain. We investigated whether fluoxetine could have broader peripheral regenerative properties.
View Article and Find Full Text PDFSci Rep
July 2024
Department of Psychiatry, University of Cambridge, Addenbrookes Hospital, Cambridge, CB2 0QQ, UK.
We used a probabilistic reversal learning task to examine prediction error-driven belief updating in three clinical groups with psychosis or psychosis-like symptoms. Study 1 compared people with at-risk mental state and first episode psychosis (FEP) to matched controls. Study 2 compared people diagnosed with treatment-resistant schizophrenia (TRS) to matched controls.
View Article and Find Full Text PDFSchizophr Bull
July 2024
Department of Psychiatry, University of Oxford, Oxford, UK.
Background And Hypothesis: Cognition has been associated with socio-occupational functioning in individuals at Clinical High Risk for Psychosis (CHR-P). The present study hypothesized that clustering CHR-P participants based on cognitive data could reveal clinically meaningful subtypes.
Study Design: A cohort of 291 CHR-P subjects was recruited through the multicentre EU-GEI high-risk study.
Neuropharmacology
November 2024
Université Paris-Saclay, Faculté de Pharmacie, Inserm UMR 1018, CESP, MOODS Team, 91400 Orsay, France. Electronic address:
Therapie
June 2024
Service hospitalo-universitaire de pharmacotoxicologie, centre régional de pharmacovigilance, hospices civils de Lyon, 162, avenue Lacassagne, 69424 Lyon cedex 03, France. Electronic address:
The objective of this cohort study was to describe the French population of pregnant women vaccinated against coronavirus disease 2019 (COVID-19), their pregnancy outcomes and the health status of their newborns (malformation rate, neonatal diseases, etc.), and to proactively collect and analyze reported adverse reactions over time. We conducted a prospective study using an online questionnaire.
View Article and Find Full Text PDFTherapie
June 2024
Agence nationale de sécurité du médicament et des produits de santé (ANSM), 93285 Saint-Denis, France.
The French National Agency for Health Products (ANSM) is a regulatory and public health agency. Its regulatory, health policing and public health protection activities require a perfect fit with the field and the various people involved in the use of health products. Since 2019, the ANSM has adapted its organisation, procedures and processes to encourage and improve interaction with its stakeholders, as part of its policy of openness towards civil society.
View Article and Find Full Text PDFBMC Psychiatry
July 2024
French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France.
Objectives: Electroconvulsive therapy (ECT) is one of the most effective treatments in mood disorders, mainly in major depressive episode (MDE) in the context of either unipolar (MDD) or bipolar disorder (BD). However, ECT remains a neglected and underused treatment. Older people are at high risk patients for the development of adverse drug reactions.
View Article and Find Full Text PDFToxins (Basel)
June 2024
Service Hospitalo-Universitaire de Pharmacotoxicologie, Hospices Civils de Lyon, 69003 Lyon, France.
We encountered a case of mushroom intoxication complicated by "toxic-like" myocarditis. Because of the lack of systematized knowledge on this subject, we performed a systematic review of the literature on cardiac toxicity in mushroom poisoning (MP). The aim of this study was to identify and describe the severity, the causal relationship, and the mushroom species involved in other reported cardiac events associated with MP.
View Article and Find Full Text PDFWorld J Biol Psychiatry
November 2024
Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland.
Background: For psychotic disorders (i.e. schizophrenia), pharmacotherapy plays a key role in controlling acute and long-term symptoms.
View Article and Find Full Text PDFPsychiatry Res
September 2024
MOODS Team, INSERM U1018, CESP, Université Paris-Saclay, Faculté de Médecine Paris-Saclay, Le Kremlin-Bicêtre F-94275, France; Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Mood Center Paris Saclay, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre F-94275, France. Electronic address:
Psychiatry Clin Neurosci
August 2024
Service Hospitalo-Universitaire de Psychiatrie, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
Background: Habenula, a hub brain region controlling monoaminergic brain center, has been implicated in major depressive disorder (MDD) and as a possible target of antidepressant response. Nevertheless, the effect of antidepressant drug treatment on habenular volumes remains unknown. The objective of the present research was to study habenular volume change after antidepressant treatment in patients with MDD, and assess whether it is associated with clinical improvement.
View Article and Find Full Text PDFNicotine Tob Res
November 2024
Unité de Recherche Clinique Pierre Deniker, Centre Hospitalier Henri Laborit, Poitiers, France.
Introduction: Increased salience of drug-related cues over nondrug reinforcers can drive drug use and contribute to tobacco use disorder (TUD). An important scientific and clinical goal is to effectively measure this elevated drug-seeking behavior in TUD. However, most TUD assessments rely on self-reported cravings and cigarette consumption, not providing an objective measure of the impact of drug cues on biasing behavior toward drugs.
View Article and Find Full Text PDFEncephale
May 2024
Service hospitalo-universitaire de santé mentale et thérapeutique-75G14, Groupe hospitalo-universitaire Paris psychiatrie et neurosciences, 1, rue Cabanis, 75014 Paris, France; Centre ressource en remédiation cognitive et réhabilitation psychosociale en île de France, Groupe hospitalo-universitaire Paris psychiatrie et neurosciences - université Paris Cité, Paris, France.
Psychiatric disorders are common and can cause psychological disabilities. While the creation of day hospitals (DHs) was intended to direct psychiatric care towards community settings, they may have paradoxically contributed to a form of chronicity. Furthermore, the heterogeneity and lack of evaluation of care within DHs prevent the availability needed to collect objective data on users outcomes.
View Article and Find Full Text PDFNeurosci Biobehav Rev
July 2024
Service Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie, Centre Hospitalier de Versailles, 177, rue de Versailles, Le Chesnay-Rocquencourt 78157, France; Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, DisAP-DevPsy-CESP, INSERM UMR1018, Villejuif 94807, France.
FRILEUX, M., BOLTRI M. and al.
View Article and Find Full Text PDFAnaesth Crit Care Pain Med
August 2024
Department of Anesthesiology and Intensive Care, Hôpital Européen Georges-Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Background: Preventive anesthetic impact on the high rates of postoperative neurocognitive disorders in elderly patients is debated. The Prevention of postOperative Cognitive dysfunction by Ketamine (POCK) study aimed to assess the effect of ketamine on this condition.
Methods: This is a multicenter, randomized, double-blind, interventional study.
Focus (Am Psychiatr Publ)
October 2023
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA (Burdick, Millett, Potter, Shanahan); University of Michigan, Ann Arbor, Michigan, USA (Yocum, Diaz-Byrd, McInnis); The Milken Institute, Washington, District of Columbia, USA (Altimus, Pham); NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway (Andreassen, Lagerberg, Ueland); KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway (Andreassen); Pôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco, Monaco (Aubin); Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France; INT-UMR7289, CNRS Aix-Marseille Université, Marseille, France (Belzeaux); Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia (Berk, Stuart, Williams, Wrobel); Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia (Berk, Wrobel); Mayo Clinic Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA (Biernacka, Frye); Mayo Clinic Department of Quantitative Health Sciences, Mayo Clinic, Rocester, MN, USA (Biernacka); Yale School of Medicine, New Haven, Connecticut, USA (Blumberg); Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK (Cleare, Strawbridge, Young); Université de Paris, INSERM UMR1266, AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France (Dubertret); Université de Paris, AP-HP, Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS, Paris, France (Etain); University of California San Diego, La Jolla, CA, USA; Desert-Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, California, USA (Eyler, Klaus); Division of Geriatric Psychiatry, McLean Hospital, Belmont, MA, USA (Forester); Harvard Medical School, Boston, Massachusetts, USA (Forester); Neuroscience Research Australia, Sydney, Australia (Fullerton); School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia (Fullerton); Pôle de Psychiatrie Générale et Universitaire, Centre Hospitalier Charles Perrens, Bordeaux, France (Gard); Univ Paris Est Créteil, INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Créteil, France; APHP, Hôpitaux Universitaires Henri Mondor, Département Médico-Universitaire de Psychiatrie et d'Addictologie, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France (Godin, Leboyer); Clinical Psychiatry Department, Treatment-Resistant Depression Fondamental Expert Center, EA 481 Neurosciences, Bourgogne Franche Comté University, Besançon, France (Haffen); Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain (Martinez-Aran, Sole, Vieta); SLM Lindner Center of HOPE, Mason, Ohio, USA; University of Cincinnati College of Medicine, Cincinnati, Ohio, USA (McElroy); School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia (Mitchell); Department of Emergency Psychiatry and Acute Care, CHU Montpellier, IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France (Olie); Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA (Olorunfemi, Peters, Nierenberg); Service Hospitalo-Universitaire de psychiatrie d'adulte et d'addictologie, Centre Hospitalier de Versailles, INSERM UMR1018, DisAP-DevPsy-CESP, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Gif-sur-Yvette, France (Passerieux); Univ. Grenoble Alpes, CHU de Grenoble et des Alpes, Grenoble Institut des Neurosciences Inserm U 1216, Grenoble, France (Polosan); University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA (Sajatovic); CHU Clermont-Ferrand, Department of Psychiatry, University of Clermont Auvergne, UMR 6602 Institut Pascal, Clermont-Ferrand, France (Samalin); Université de Lorraine, Inserm U 1114, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie CPN, Laxou, France (Schwan); Department of Psychiatry, University of British Columbia, Vancouver, Canada (Torres, Yatham); Department of Psychology, University of Oslo, Oslo, Norway (Ueland); Barwon Health, Geelong, Victoria, Australia (Williams).
Objectives: Persistent functional impairment is common in bipolar disorder (BD) and is influenced by a number of demographic, clinical, and cognitive features. The goal of this project was to estimate and compare the influence of key factors on community function in multiple cohorts of well-characterized samples of individuals with BD.
Methods: Thirteen cohorts from 7 countries included = 5882 individuals with BD across multiple sites.
Bipolar Disord
August 2024
Département de Psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France.
Background: One of the challenges in bipolar disorder (BD) lies in early detection of the illness and its recurrences, to improve prognosis. Sleep disturbances (SD) have been proposed as reliable predictive markers of conversion. While preliminary studies have explored the relationship between SD and the onset of mood episodes, the results remain heterogeneous and a few have specifically examined patients' perception of prodromal symptoms and their progression until the episode occurs.
View Article and Find Full Text PDFAnn Am Thorac Soc
July 2024
Université Paris Cité, Institut Cochin, INSERM U1016, Paris, France.
Limited data exist on the safety and effectiveness of elexacaftor-tezacaftor-ivacaftor (ETI) in people with cystic fibrosis (pwCF) and advanced lung disease. To evaluate the effects of ETI in an unselected population of pwCF and advanced lung disease. A prospective observational study, including all adults aged 18 years and older with percentage predicted forced expiratory volume in 1 second (ppFEV) ⩽ 40 who initiated ETI from December 2019 to June 2021 in France, was conducted.
View Article and Find Full Text PDFSchizophr Res
May 2024
Inserm UMR-S 1237 PhIND, Presage team, GIP Cyceron, 14000 Caen, France; Centre Hospitalier du Rouvray, Service Hospitalo-Universitaire de Psychiatrie, Centre Thérapeutique d'Excellence, 76300 Sotteville-lès-Rouen, France; Fédération Hospitalo-Universitaire (FHU) A2M2P- CHU, Caen 14000, France.
Background: A scale for self-assessment of auditory verbal hallucinations (SAVH) was developed for patients, and this study aimed to validate the scale by investigating its psychometric properties.
Methods: Forty one patients with schizophrenia or schizoaffective disorders (DSM-5) self-assessed their hallucinations using nine SAVH questions. Each question was scored from 0 to 5, indicating the severity of the symptoms.
Lancet Psychiatry
April 2024
Université Paris Cité and Université Sorbonne Paris Nord, INSERM INRAE, Centre for Research in Epidemiology and Statistics, Paris, France; Centre d'Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, Paris, France. Electronic address:
Research waste occurs when randomised controlled trial (RCT) outcomes are heterogeneous or overlook domains that matter to patients (eg, relating to symptoms or functions). In this systematic review, we reviewed the outcome measures used in 450 RCTs of adult unipolar and bipolar depression registered between 2018 and 2022 and identified 388 different measures. 40% of the RCTs used the same measure (Hamilton Depression Rating Scale [HAMD]).
View Article and Find Full Text PDFEur Neuropsychopharmacol
August 2023
Université Paris Cité Inserm UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, 75006, Paris, France; Fondation FondaMental, 94010, Créteil, France; Centres Experts Trouble Bipolaire et Dépression Résistante, Assistance Publique des Hôpitaux de Paris, Hôpital Lariboisière-Fernand Widal, 75010 Paris, France.
Monitoring of lamotrigine levels is recommended in epilepsy. However, in bipolar disorders (BD), no study has described the therapeutic range in daily practice and factors being associated to it. We used retrospective data of individuals with BD, treated with lamotrigine, and included in the FondaMental Advanced Centers of Expertise for Bipolar Disorders cohort.
View Article and Find Full Text PDFEur J Hosp Pharm
March 2024
Pôle Pharmacie, Service Hospitalo-Universitaire de Pharmacie, CHU Rennes, Rennes, 35000, Rennes, France
Objectives: Therapeutic patient education (TPE) plays a critical role in the management of kidney transplant recipients. However, discrepancies exist in the guidance provided regarding the usage of immunosuppressants across different kidney transplant centres in France.
Methods: To assess the current landscape of TPE practices in this patient population, an online questionnaire consisting of 51 questions was distributed to 32 French renal transplantation centres.